Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model

Journal of Neurosurgery: Spine

Volumn 7, Issue 1, 2007, Pages 54-60

  Byung, Hyune Choi ^a,b   Yoon, Ha ^a,b   Huang, Xian ^a,b   So, Ra Park ^a,b   Chung, Joonho ^a,b   Dong, Keun Hyun ^a,b   Park, Hyeonseon ^a,b   Hyung, Chun Park ^a,b   Sung, Wan Kim ^c   Lee, Minhyung ^d  

^a Inha University School of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c UNIVERSITY OF UTAH   (United States)

^d Hanyang University   (South Korea)

Author keywords

Gene therapy; Hypoxia; Spinal cord injury; Transcription regulation; Vascular endothelial growth factor

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; ERYTHROPOIETIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HYPOXIA; IN VITRO STUDY; LOCOMOTION; NERVE CELL; NICK END LABELING; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RAT STRAIN; RATING SCALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; SPINAL CORD; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANOXIA; APOPTOSIS; ASTROCYTES; CELL LINE, TUMOR; ENHANCER ELEMENTS (GENETICS); ERYTHROPOIETIN; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; MALE; MICE; MOTOR ACTIVITY; NEURONS; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; SIMIAN VIRUS 40; SPINAL CORD; SPINAL CORD INJURIES; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447543006     PISSN: 15475654     EISSN: None     Source Type: Journal    
DOI: 10.3171/SPI-07/07/054     Document Type: Article

References (30)

1. Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21, 1995
2. Benton RL, Whittemore SR: VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem Res 28:1693-1703, 2003
3. Brockington A, Lewis C, Wharton S, Shaw PJ: Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol 30:427-446, 2004
4. Cao YJ, Shibata T, Rainov NG: Hypoxia-inducible transgene expression in differentiated human NT2N neurons - a cell culture model for gene therapy of postischemic neuronal loss. Gene Ther 8:1357-1362, 2001
5. Facchiano F, Fernandez E, Mancarella S, Maira G, Miscusi M, D'Arcangelo D, et al: Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 97:161-168, 2002
6. Fehlings MG, Tator CH, Linden RD: The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 74:241-259, 1989
7. Gaviria M, Haton H, Sandillon F, Privat A: A mouse model of acute ischemic spinal cord injury. J Neurotrauma 19:205-221, 2002
8. Giordano FJ, Gerber HP, Williams SP, Van Bruggen N, Bunting S, Ruiz-Lozano P, et al: A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 98:5780-5785, 2001
9. Ha Y, Kim YS, Cho JM, Yoon SH, Park SR, Yoon DH, et al: Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J Neurosurg Spine 2:55-61, 2005
10. Hulsebosch CE: Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Edu 26:238-255, 2002
11. Ju Y, He M, Mao B: Sequential changes of hypoxia-inducible factor 1 alpha in experimental spinal cord injury and its significance. Chin J Traumatol 5:103-106, 2002
12. Koyanagi I, Tator CH, Lea PJ: Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts. Part 2: acute spinal cord injury. Neurosurgery 33:285-292, 1993
13. Lee M, Bikram M, Oh S, Bull DA, Kim SW: Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res 21:736-741, 2004
14. Lee M, Lee ES, Kim YS, Choi BH, Park SR, Park HS, et al: Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system. Spine 30:2729-2734, 2005
15. Lee M, Rentz J, Bikram M, Han S, Bull DA, Kim SW: Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 10:1535-1542, 2003
16. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901, 2000
17. Lu K, Liang CL, Chen HJ, Chen SD, Hsu HC, Liliang PC, et al: Injury severity and cell death mechanisms: effects of concomitant hypovolemic hypotension on spinal cord ischemia-reperfusion in rats. Exp Neurol 185:120-132, 2004
18. Maxwell PH, Pugh CW, Ratcliffe PJ: Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A 90:2423-2427, 1993
19. Namiki J, Kojima A, Tator CH: Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma 17:1219-1231, 2000
20. Ogura M, Shibata T, Yi J, Liu J, Qu R, Harada H, et al: A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinoma. Cancer Sci 96:288-294, 2005
21. Park E, Velumian AA, Fehlings MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754-774, 2004
22. Rivlin AS, Tator CH: Regional spinal cord blood flow in rats after severe cord trauma. J Neurosurg 49:844-853, 1978
23. Rosenstein JM, Krum JM: New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187:246-253, 2004
24. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, et al: Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283-2293, 2002
25. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM: VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 2:549-558, 1998
26. Storkebaum E, Lambrechts D, Carmeliet P: VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26:943-954, 2004
27. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991
28. Tator CH, Koyanagi I: Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 87:483-492, 1997
29. Wallace MC, Tator CH, Frazee P: Relationship between posttraumatic ischemia and hemorrhage in the injured rat spinal cord as shown by colloidal carbon angiography. Neurosurgery 18:433-439, 1986
30. Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, et al: Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120:951-960, 2003